Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Arvind Remedies Ltd Recommends Dividend; Approves Demerger of Irungattukottai Unit Into Wholly Owned Subsidiary


Wednesday, 15 May 2013 11:41pm EDT 

Arvind Remedies Ltd announced that the Board of Directors at its meeting the board has recommended a dividend of INR1 per equity share (including 2% special dividend due to Silver Jubilee year) of INR10 each. The Company also approved the Demerger of Irungattukottai Unit of the Company into their Wholly Owned Subsidiary (WOS), Arvind Wellness Limited and fixed the appointed date as April 08, 2013. 

Company Quote

23.3
-1.6 -6.43%
5:28am EST